Addressing sources of bias in the GRAND study protocol in India

IF 2.7 3区医学 Q2 PERIPHERAL VASCULAR DISEASE Journal of Clinical Hypertension Pub Date : 2024-10-03 DOI:10.1111/jch.14901

Narsingh Verma MBBS, MD, Noriko Matsushita MPH, Ebtehal Salman PhD, Takayoshi Ohkubo MD, PhD, Yutaka Imai MD, PhD

{"title":"Addressing sources of bias in the GRAND study protocol in India","authors":"Narsingh Verma MBBS, MD, Noriko Matsushita MPH, Ebtehal Salman PhD, Takayoshi Ohkubo MD, PhD, Yutaka Imai MD, PhD","doi":"10.1111/jch.14901","DOIUrl":null,"url":null,"abstract":"One additional note to mention is that the sample size of our study population is not considered large compared to India's population, and there were indeed limitations in our study, however, clinical studies using home BP monitoring (HBPM) in India are limited. Our GRAND Study is the first step toward understanding the “real” BP control status using both clinic BP and home BP and the current hypertension situation in India. We believe that the GRAND Study will contribute to understanding hypertension management based on HBPM, and we anticipate that future national studies in India will also incorporate HBPM.We appreciate the constructive feedback on our protocol. We believe the mentioned insights align well with our goal of providing a comprehensive and accurate assessment of hypertension prevalence and BP control in India. We are committed to incorporating these insights in analyzing the results of the study and in future publications to ensure proper interpretations of the study findings and implications.Noriko Matsushita and Ebtehal Salman is an employee of Omron Healthcare Co., Ltd. Takayoshi Ohkubo and Yutaka Imai has received grants from Omron Healthcare Co., Ltd.This study was supported and research funded by Omron Healthcare Co., Ltd.","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":"26 12","pages":"1531-1532"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.14901","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.14901","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

Abstract

One additional note to mention is that the sample size of our study population is not considered large compared to India's population, and there were indeed limitations in our study, however, clinical studies using home BP monitoring (HBPM) in India are limited. Our GRAND Study is the first step toward understanding the “real” BP control status using both clinic BP and home BP and the current hypertension situation in India. We believe that the GRAND Study will contribute to understanding hypertension management based on HBPM, and we anticipate that future national studies in India will also incorporate HBPM.

We appreciate the constructive feedback on our protocol. We believe the mentioned insights align well with our goal of providing a comprehensive and accurate assessment of hypertension prevalence and BP control in India. We are committed to incorporating these insights in analyzing the results of the study and in future publications to ensure proper interpretations of the study findings and implications.

Noriko Matsushita and Ebtehal Salman is an employee of Omron Healthcare Co., Ltd. Takayoshi Ohkubo and Yutaka Imai has received grants from Omron Healthcare Co., Ltd.

This study was supported and research funded by Omron Healthcare Co., Ltd.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

解决印度 GRAND 研究方案中的偏差来源。

另外需要注意的是，与印度的人口相比，我们的研究人群的样本量并不大，我们的研究确实存在局限性，然而，在印度使用家庭血压监测（HBPM）的临床研究是有限的。我们的GRAND研究是了解“真实”血压控制状态的第一步，使用临床血压和家庭血压以及印度当前的高血压情况。我们相信GRAND研究将有助于理解基于HBPM的高血压管理，我们预计印度未来的全国性研究也将纳入HBPM。我们感谢对我们的协议的建设性反馈。我们相信上述见解与我们提供印度高血压患病率和血压控制的全面准确评估的目标是一致的。我们致力于将这些见解纳入研究结果的分析和未来的出版物中，以确保对研究结果和影响的正确解释。Noriko Matsushita和Ebtehal Salman是欧姆龙医疗保健有限公司的员工。Takayoshi Ohkubo和Yutaka Imai获得了欧姆龙医疗保健有限公司的资助，本研究得到了欧姆龙医疗保健有限公司的支持和研究资金。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Clinical Hypertension PERIPHERAL VASCULAR DISEASE-

CiteScore

5.80

自引率

7.10%

发文量

191

审稿时长

4-8 weeks

期刊介绍： The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.